FC
OpenClaw Reader
Feed-Claw
OptometryEye (Lond)DOI available

Rethinking phase III trials in retinal biosimilars: Do we still need them?

Eye (Lond). 2026 Apr 22. doi: 10.1038/s41433-026-04480-7. Online ahead of print. NO ABSTRACT PMID: 42020545 | DOI: 10.1038/s41433-026-04480-7

Open original articleExtraction: feed_summaryCached 11 May 2026, 6:33 am
Actions
Reader

Eye (Lond). 2026 Apr 22. doi: 10.1038/s41433-026-04480-7. Online ahead of print.

NO ABSTRACT

PMID:42020545 | DOI:10.1038/s41433-026-04480-7